Randy L Wei1, Brian C Jung1, Wilfred Manzano1, Varun Sehgal1, Samuel J Klempner2, Steve P Lee3, Nilam S Ramsinghani1, Chandana Lall4. 1. Department of Radiation Oncology, University of California Irvine, Orange, USA. 2. Department of Medicine, Division of Hematology-Oncology, University of California Irvine, Orange, USA. 3. Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, USA. 4. Department of Radiology, University of California Irvine, Orange, USA. Electronic address: clall@uci.edu.
Abstract
PURPOSE: To investigate the relationship between abdominal chemoradiation (CRT) for locally advanced cancers and bone mineral density (BMD) reduction in the vertebral spine. MATERIALS AND METHODS: Data from 272 patients who underwent abdominal radiation therapy from January 1997 to May 2015 were retrospectively reviewed. Forty-two patients received computed tomography (CT) scans of the abdomen prior to initiation and at least twice after radiation therapy. Bone attenuation (in Hounsfield unit) (HU) measurements were collected for each vertebral level from T7 to L5 using sagittal CT images. Radiation point dose was obtained at each mid-vertebral body from the radiation treatment plan. Percent change in bone attenuation (Δ%HU) between baseline and post-radiation therapy were computed for each vertebral body. The Δ%HU was compared against radiation dose using Pearson's linear correlation. RESULTS: Abdominal radiotherapy caused significant reduction in vertebral BMD as measured by HU. Patients who received only chemotherapy did not show changes in their BMD in this study. The Δ%HU was significantly correlated with the radiation point dose to the vertebral body (R=-0.472, P<0.001) within 4-8 months following RT. The same relationship persisted in subsequent follow up scans 9 months following RT (R=-0.578, P<0.001). Based on the result of linear regression, 5 Gy, 15 Gy, 25 Gy, 35 Gy, and 45 Gy caused 21.7%, 31.1%, 40.5%, 49.9%, and 59.3% decrease in HU following RT, respectively. Our generalized linear model showed that pre-RT HU had a positive effect (β=0.830) on determining post-RT HU, while number of months post RT (β=-0.213) and radiation point dose (β=-1.475) had a negative effect. A comparison of the predicted versus actual HU showed significant correlation (R=0.883, P<0.001) with the slope of the best linear fit=0.81. Our model's predicted HU were within ±20 HU of the actual value in 53% of cases, 70% of the predictions were within ±30 HU, 81% were within ±40 HU, and 90% were within ±50 HU of the actual post-RT HU. Four of 42 patients were found to have vertebral body compression fractures in the field of radiation. CONCLUSIONS: Patients who receive abdominal chemoradiation develop significant BMD loss in the thoracic and lumbar vertebrae. Treatment-related BMD loss may contribute to the development of vertebral compression fractures. A predictive model for post-CRT BMD changes may inform bone protective strategies in patients planned for abdominal CRT.
PURPOSE: To investigate the relationship between abdominal chemoradiation (CRT) for locally advanced cancers and bone mineral density (BMD) reduction in the vertebral spine. MATERIALS AND METHODS: Data from 272 patients who underwent abdominal radiation therapy from January 1997 to May 2015 were retrospectively reviewed. Forty-two patients received computed tomography (CT) scans of the abdomen prior to initiation and at least twice after radiation therapy. Bone attenuation (in Hounsfield unit) (HU) measurements were collected for each vertebral level from T7 to L5 using sagittal CT images. Radiation point dose was obtained at each mid-vertebral body from the radiation treatment plan. Percent change in bone attenuation (Δ%HU) between baseline and post-radiation therapy were computed for each vertebral body. The Δ%HU was compared against radiation dose using Pearson's linear correlation. RESULTS: Abdominal radiotherapy caused significant reduction in vertebral BMD as measured by HU. Patients who received only chemotherapy did not show changes in their BMD in this study. The Δ%HU was significantly correlated with the radiation point dose to the vertebral body (R=-0.472, P<0.001) within 4-8 months following RT. The same relationship persisted in subsequent follow up scans 9 months following RT (R=-0.578, P<0.001). Based on the result of linear regression, 5 Gy, 15 Gy, 25 Gy, 35 Gy, and 45 Gy caused 21.7%, 31.1%, 40.5%, 49.9%, and 59.3% decrease in HU following RT, respectively. Our generalized linear model showed that pre-RT HU had a positive effect (β=0.830) on determining post-RT HU, while number of months post RT (β=-0.213) and radiation point dose (β=-1.475) had a negative effect. A comparison of the predicted versus actual HU showed significant correlation (R=0.883, P<0.001) with the slope of the best linear fit=0.81. Our model's predicted HU were within ±20 HU of the actual value in 53% of cases, 70% of the predictions were within ±30 HU, 81% were within ±40 HU, and 90% were within ±50 HU of the actual post-RT HU. Four of 42 patients were found to have vertebral body compression fractures in the field of radiation. CONCLUSIONS:Patients who receive abdominal chemoradiation develop significant BMD loss in the thoracic and lumbar vertebrae. Treatment-related BMD loss may contribute to the development of vertebral compression fractures. A predictive model for post-CRT BMD changes may inform bone protective strategies in patients planned for abdominal CRT.
Authors: Michael Farris; Emory R McTyre; Catherine Okoukoni; Greg Dugan; Brendan J Johnson; A William Blackstock; Michael T Munley; J Daniel Bourland; J Mark Cline; Jeffrey S Willey Journal: Radiat Res Date: 2018-05-08 Impact factor: 2.841
Authors: Megan M Pendleton; Shannon R Emerzian; Jennifer Liu; Simon Y Tang; Grace D O'Connell; Joshua S Alwood; Tony M Keaveny Journal: Bone Date: 2019-08-21 Impact factor: 4.398
Authors: V Nardone; P Tini; S F Carbone; A Grassi; M Biondi; L Sebaste; T Carfagno; E Vanzi; G De Otto; G Battaglia; G Rubino; P Pastina; G Belmonte; L N Mazzoni; F Banci Buonamici; M A Mazzei; L Pirtoli Journal: Osteoporos Int Date: 2017-02-27 Impact factor: 4.507
Authors: Olivier van Wulfften Palthe; Kyung-Wook Jee; Jos A M Bramer; Francis J Hornicek; Yen-Lin E Chen; Joseph H Schwab Journal: Clin Orthop Relat Res Date: 2018-03 Impact factor: 4.176
Authors: Megan E Oest; Connor G Policastro; Kenneth A Mann; Nicholas D Zimmerman; Timothy A Damron Journal: J Bone Miner Res Date: 2017-10-04 Impact factor: 6.741
Authors: Diddier Prada; Jia Zhong; Elena Colicino; Antonella Zanobetti; Joel Schwartz; Nicholas Dagincourt; Shona C Fang; Itai Kloog; Joseph M Zmuda; Michael Holick; Luis A Herrera; Lifang Hou; Francesca Dominici; Benedetta Bartali; Andrea A Baccarelli Journal: Lancet Planet Health Date: 2017-11-09
Authors: Qurrat U van den Blink; Kate Garcez; Caroline C Henson; Susan E Davidson; Claire E Higham Journal: Cochrane Database Syst Rev Date: 2018-04-23